Pioglitazone Hydrochloride Tablet
Product Images NDC 70518-4519

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone Hydrochloride (NDC 70518-4519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Pioglitazone Tablet 45 mg, oral tablets, packaged quantity of 90 tablets. The label includes the NDC 70518-4519-00 and manufacturing information by Aurobindo, Nagar, India. It is labeled as RX only and repackaged by RemedyRepack Inc., Indiana, PA.*

FDA Label Image

Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)

A line graph showing mean change from baseline in HbA1c over 26 weeks in a placebo-controlled dose-ranging study for pioglitazone hydrochloride tablets. The x-axis represents time in weeks, and the y-axis shows the mean change. Four lines correspond to placebo, 15 mg, 30 mg, and 45 mg doses, indicating changes in HbA1c values over time.*

FDA Label Image

Chemical Structure (Pioglitazone Str)

Chemical structure of pioglitazone hydrochloride depicting its molecular configuration with various functional groups including a pyridine ring and thiazolidinedione moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.